- Open Access
Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy
© Khaitan et al; licensee BioMed Central Ltd. 2006
- Received: 25 January 2006
- Accepted: 02 March 2006
- Published: 02 March 2006
Multicellular spheroids, an appropriate in vitro system for simulating 3-D tumor micro-milieu can be used for evaluating and predicting tumor response to therapeutic agents including metabolic inhibitors. However, detailed understanding of the nature, distribution and sensitivity/responses of cellular sub-populations to potential therapeutic agents/strategies is required for using this unique model with optimal precision. Spheroid characteristics may also vary considerably with the origin and type of cell line used, and thorough characterization of viable and dissociated glioma cell spheroids is not yet completely known. In order to evaluate in vivo responses of gliomas to various therapeutic strategies, especially the metabolic inhibitors capable of penetrating the blood brain barrier, we have characterized continuously growing spheroids of a human glioma cell line (BMG-1) with respect to organization, growth, viability, cell survival, cell death, metabolic and mitochondrial status, oxidative stress and radiation response using microscopy, flow cytometry and enzymatic assays. Spheroids were fed daily with fresh medium in order to maintain nutrient supply to outer cellular layers while hypoxia/necrosis developed in the innermost cells of enlarging spheroids.
Volume of spheroids, fed daily with fresh medium, increased exponentially during 7–28 days of growth through three population doublings. Proportion of G1-phase cells was higher (~60%) than exponentially growing monolayer cells (~48%). A significant fraction of S-phase cells turned metabolically inactive (disengaged in DNA synthesis) with increasing age of the spheroids, unlike in quiescent monolayer cultures, where the fraction of S-phase cells was less than 5%. With increasing spheroid size, increasing sub-populations of cells became non-viable and entered apoptosis or necrosis revealed by Annexin-V-FITC/PI staining. PI positive (necrotic) cells were not confined to the centre of the spheroid, but distributed at certain discrete foci. Average glucose consumption and lactate production were 2–3 folds higher in viable spheroid cells compared to monolayer cells, implying a compensatory increase in glycolysis possibly due to hypoxic environment. HIF-1α was expressed only in spheroids and increased in an age-dependent manner, whereas c-Myc (known to induce apoptosis in glucose-deprived cells) levels were three times higher than monolayer cells. Mitochondrial mass and activity decreased significantly during first 14 days of growth but increased with age, and were not associated with increase in ROS levels. Bcl-2 and Bax levels were higher (~2 folds) than monolayers, while the ratio (Bcl/Bax) remained unaltered. Radiation-induced oxidative stress was considerably less in spheroids as compared to monolayers, and corresponded well with increase in radioresistance demonstrated by the clonogenic assay, similar to hypoxia induced radioresistance observed in tumors.
Development of S-negative cells and reduced endogenous and radiation-induced ROS coupled with higher levels of anti (Bcl2) as well as pro (Bax) apoptotic regulators observed in spheroids suggest the intricate/complex nature of endogenous as well as induced stress resistance that could exist in tumors, which contribute to the treatment resistance.
- Monolayer Culture
- Lactate Production
- Cell Cycle Distribution
- Hypoxic Cell
- Human Glioma Cell Line
Cells of actively growing tumors are exposed to varying micro-environmental conditions due to non-homogeneous vascular supply , leading to the development of localized regions in tumors having low oxygen tension, low glucose concentration and acidic extracellular pH due to accumulation of metabolic by-products such as lactic acid. As a result, cells in these regions are exposed to varying levels of hypoxia, anoxia and acidosis . From the radiobiological point of view, hypoxic cells constitute the most important cellular subpopulation because they are more radioresistant than the euoxic cells as a result of reduced generation of radiation-induced reactive oxygen species or ROS [3, 4]. The hypoxic cell fraction increases considerably with the advancement of tumor size and grade offering significant resistance to radiotherapy. The currently used hypoxic cell sensitizers (nitroimadazole compounds) have met with limited success due to the lack of differential effect besides systemic toxicity. Therefore, there is a need to develop effective strategies to selectively enhance the radiosensitivity of these cells, which requires a detailed characterization of the nature and responses of these resistant cellular fractions. Since hypoxic cells exist in three-dimensional tumors that behave as heterogeneous systems demonstrating alterations in many vital genotypic and phenotypic characteristics regulating various biological processes, an in vitro cellular model that closely simulates these conditions is essential for carrying out studies on hypoxic cell and tumor responses to therapeutic agents.
Monolayer cultures of established cell lines from human tumors have been widely used for studying the various molecular processes including the identification of specific molecular lesions related to the dysregulation of cell proliferation and cell death, the two important functional targets for the development of therapies. Unfortunately, investigations necessary for the development and/or evaluation of some of the therapeutic strategies cannot be carried out with this most widely used laboratory system, since complexities arising out of 3-dimensional organization of solid tumors (viz., cell-cell/cell-matrix interactions and variations in vasculature and nutrient supply) resulting in subtle changes in phenotypic expression (especially the metabolic changes) are not provided in the monolayer cultures derived from tumor cells. In contrast, multicellular spheroids of tumor cells provide an excellent three-dimensional in vitro model in which hypoxic conditions can be generated to facilitate detailed investigations including the response to various chemical agents and radiation [5, 6].
Spheroids are characterized by high cell-density and a closely packed, 3-D tumor like structure, which leads to severe diffusion limitations for molecules as small as glucose and oxygen, thereby creating heterogeneous cell sub-populations of actively proliferating as well as quiescent, hypoxic and necrotic cells as found in solid tumors . Available evidences suggest that low concentration of glucose and oxygen in the inner regions of spheroids may contribute to the formation of quiescent, hypoxic, anoxic and necrotic cell sub-populations [8–10]. Characterization of the nature of these cell sub-populations as well as their responses to radiation and radiomodifying agents can help in the development of more effective radiosensitizing strategies. For example, hypoxic cells are known to derive a large part of their energy from glucose-dependent anaerobic metabolic pathways. Therefore, inhibitors of glycolysis could specifically modify the responses of this resistant sub-population of cancer cells. A number of in vitro studies have indeed shown that 2-DG, a glucose analogue and inhibitor of glycolytic ATP production [11–13], selectively inhibits energy-dependent DNA repair and cellular recovery processes in cancer cells [14–16] resulting in enhanced cell death [11, 13, 17, 18]. Spheroids could serve a very useful model to understand further the mechanisms of radiosensitivity induced by this glycolytic inhibitor in solid tumors, since spheroids mimic the solid tumors more closely than the monolayer culture.
Spheroids have been used for a broad spectrum of studies in cancer biology and employed extensively in radiobiological investigations  as they provide a good in vitro system to mimic the radioresistant hypoxic cell population generally found in tumors. Unfortunately however, detailed information available on the intercellular variation in mitochondrial mass, activity and ROS levels (oxidative stress mainly responsible for damage induced by low LET radiation) as a function of spheroid growth and with reference to other parameters like viability cell death etc in culture is lacking. These parameters influence the end results of in vitro studies aimed at understanding tumour response to various cytotoxic agents and metabolic inhibitors. Therefore, the present study was undertaken to systematically characterize spheroids established from a human glioma cell line BMG-1 [11, 20] with respect to organization, growth, viability and cell survival, cell death, metabolic and mitochondrial status, oxidative stress and radiation response with age and spheroid size using microscopy, flow cytometry and enzymatic assays.
The results of the present studies demonstrate development of S-negative cells, reduced endogenous and radiation-induced ROS besides changes in levels of anti (Bcl2) as well as pro (Bax) apoptotic regulators observed in spheroids which suggest the intricate/complex nature of endogenous as well as induced stress resistance that could exist in tumors, which contribute to the treatment resistance.
Spheroid size and cellular characteristics as a function of age in spheroids.
Age of spheroids in days
Av. volume × 10-6(μm3)
Avg. No. of cells/spheroid
Avg. Cellular Diameter (μm)
Cell packing density
Plating Efficiency (%)
93 ± 5
1176 ± 39
13 ± 1
98 ± 1.4
65 ± 0.6
148 ± 10
2222 ± 47
7 ± 1(20%); 14 ± 1
78 ± 1.9
63 ± 0.2
157 ± 11
4236 ± 63
10 ± 1 (25%); 16 ± 1 (63%); 24 ± 2 (12%)
77 ± 1.7
45 ± 0.2
242 ± 19
8975 ± 78
19 ± 2
70 ± 3.2
25 ± 0.1
Cell cycle distribution
Comparison of cell cycle distribution in exponentially growing monolayers and spheroids studied as a function of age.
Age of spheroids in days
Total S Phase Cells
48 ± 3
40 ± 1
40 ± 1
12 ± 1
72 ± 2
3 ± 2
3 ± 2
25 ± 4
59 ± 2
20 ± 3
18 ± 3
2 ± 0.5
21 ± 2
59 ± 2
20 ± 1
9 ± 1
11 ± 1
21 ± 1
56 ± 3
19 ± 2
6 ± 2
13 ± 1
25 ± 3
58 ± 4
19 ± 1
5 ± 1
14 ± 1
23 ± 1
Glucose usage and lactate production
Comparision of glucose usage lactate production and radiation response in the exponentially growing monolayers and as a function of age in spheroids.
Glucose utilization (pico mole/cell/h)
Lactate production (pico mole/cell/h)
0.83 ± 0.03
1.47 ± 0.01
0.8 ± 0.04
7 day spheroid
2.10 ± 0.07
3.67 ± 0.04
0.9 ± 0.03
28 day spheroid
1.85 ± 0.05
2.93 ± 0.02
1.0 ± 0.06
Alterations in HIF-1α, c-Myc, Bcl2 and Bax protein levels
Endogenous and ionizing radiation induced ROS generation in spheroids
Rh-123 is a cell-permeant cationic fluorescent dye that is readily sequestered by functionally active mitochondria having intact membrane potential. Relative fluorescence intensity of the spheroids significantly decreased significantly at 7 and 14 days as compared to the monolayers (Fig 8b). This was followed by an abrupt increase in the mitochondrial activity in the 28-day-old spheroids, although the mitochondrial mass did not increase.
Appropriate in vitro models play a vital role in understanding various molecular processes underlying tumor biology besides the development and evaluation of new therapeutic agents and strategies for improving cancer therapy. Spheroids are in vitro 3-D model that simulates tumor micro-milieu and have been vastly used to understand different aspects of tumor biology. Therefore in vitro models that permit reproducible experimental studies are expected to greatly facilitate the development of newer and effective therapeutic strategies. We discuss here some of the aspects of a spheroid model developed from a human glioma cell line (BMG-1), particularly with respect to the nature and distribution of various spheroidal cell populations with increasing age and size of spheroids to understand their behaviour, particularly related to the metabolism and radiation response.
Spheroid growth and appearance of S-phase quiescent (S0) cells
Spheroids are a three-dimensional cellular system that closely simulates conditions existing in the under-perfused solid tumors wherein cellular heterogeneity develops due to increasing distances from the nourishing blood capillaries . In the present study, spheroids grown from an established human glioma cell line (BMG-1) showed an exponential growth pattern up to 28 days in culture, followed by rapid disintegration. While spheroids had a consistently higher proportion of G1 population as compared to monolayers (Table 2), their cell cycle distribution (G0/G1, S and G2/M phases) did not vary with growth between 7 and 28 days, except that the fraction of S-phase cells actively synthesizing DNA (S-positive cells) reduced drastically from 18% on day-7 to 5% on day-28, with the total S-phase population remaining nearly unchanged at 20% (Fig 3, Table 2). This was in contrast with the monolayer cultures wherein all the S phase cells were S positive even as they reached quiescence (Fig 3, Table 2). Cells in the spheroids are known to accumulate in a quiescent state as the growth advances [2, 23, 24], presumably due to micro-environmental stresses such as deprivation of growth factors  and/or nutrients  or the production of inhibitory factors [24, 27] induced within the mass of spheroids. In the present study, S-phase quiescence was observed despite a consistent cell proliferation and exponential increase in spheroid volume up to 28 days (Table 1). It appears, therefore, that spheroid-specific factors like hypoxia and intercellular interactions that are different as compared to the monolayer culture mimic the conditions in large solid tumors, which result in a different type of quiescence. In contrast with the previously reported studies, we replenished the medium daily as our spheroids were unstable if not fed for long intervals of time. Regular replenishment of medium may closely resemble in vivo conditions in which tumor cells having sufficient vascular supply continuously receive fresh nutrients.
Cell cycle distribution and radioresistance
It is pertinent to note here that the cell cycle distribution at the time of irradiation is an important determinant of cell survival. Cells show considerable amount of variation in the radiosensitivity as a function of their position in the cell cycle, with S phase cells being more resistant, while cells in the G2 and M are most sensitive. However, the relative radioresistance of spheroids (Table 3) could not be attributed to this phenomenon, as the fraction of cells in the relatively resistant S-phase was lower (~20%) in spheroids as compared to the monolayer cells (~40%). Further it is also interesting to note that the fraction of S positive cells (actively engaged in DNA synthesis, generally efficient in DNA repair) also decreased from 18% at day 7 to 5% at day 28 (Table 2) in the spheroids, while the Dq values increased from 1.8 to 2.8 under these conditions.
Variations in cell size and cell packing density
Earlier studies have generally assumed the cell packing density to be constant throughout the growth of spheroids, and the cell population doubling time has been considered same as the volume doubling time . However, our results clearly show that assuming a constant cell density may not be appropriate especially when the spheroid is cultured for long intervals of time (four weeks in this case) and/or when they are slow growing. The average cell packing density decreased from 0.36 to 0.16 with the growth of spheroids from 7th day to 28th day, associated with a significant increase in the average size of cells (Table 1). Therefore, the cellular load inferred from mere volume measurements during spheroid growth could be misleading.
Incidence of cell death versus cellular radioresistance
Cell survival under conditions of hypoxic stress depends on the glycolytic status of cells  and the cellular resistance to hypoxia-induced apoptosis . A decrease in the clonogenicity (plating efficiency) and viability was generally observed with increase in the size of spheroids (Table I), which could be associated with the induction of programmed cell death or necrosis. The Annexin-V labeling assay revealed the presence of secondary necrotic (Ann-V+ve/PI+ve) cells in the absence of apoptotic (Ann-V+ve/PI-ve) cells on days 7, 21 & 28, indicating that apoptosis may be a rather quick process in these cells, obscuring the detection of early stages.
Interestingly, although the plating efficiency was significantly reduced (25%) in the 28-day spheroids, the survival curve suggested a very high radioresistance of the surviving spheroid cells (Table 1 &3). However, these surviving cells did not belong to a specific cell-cycle phase (Table 2), implying the involvement of metabolic or other processes in radiation resistance.
Enhanced glycolysis, hypoxia and radiation resistance
Many factors associated with hypoxia and related alterations in the metabolism have profound influence on the radiation response of cells. For example, hypoxic tumor cells generally show resistance to low LET radiation (X-rays), which has been suggested to be primarily due to the reduced radiation-induced ROS generation, responsible for the cell death through the induction of macromolecule damage, mainly in the form of DNA strand breaks . However, enhanced anaerobic glycolysis, leading to accumulation of lactate may also facilitate recovery process as shown in the monolayer cells held for a few hours in high lactate medium [32, 33]. In the present study, glucose utilization as well as lactate production was 2–3 fold higher in the spheroids, (Table 3) with a corresponding increase in the resistance to radiation-induced cell death (Table 3, Fig 6) as compared to the monolayer cultures. However, a distinct increase in the lactate production could not be observed in 7 day old spheroids, in-spite of Hif induction (Fig. 5), which is rather surprising and needs further investigations including the analysis of LDH. These results also suggest that, concomitant to the development of spheroid (which results in an altered cell-to-cell interaction as compared to the monolayers); there is alteration in the pattern of metabolism with further increase in glucose dependence.
Glucose usage observed in tumors often correlate with resistance to therapy and poor prognosis [34, 35]. Further, we have recently observed that the radiosensitization by 2-deoxy-D-glucose (2-DG), an inhibitor of glucose transport and glycolysis, was 2–3 folds higher than in monolayers cells, which correlated well with the difference in glucose usage between the two systems . This enhanced glucose usage and lactate production (anaerobic glycolysis) could be on account of compensatory increase in the constitutive level of expression of glycolytic enzymes, leading to a high rate of glycolytic capacity . The activity of hexokinases is highly elevated in rapidly growing tumors as compared to normal cells [38–40]. The oxygen sensor HIF-1α also induces the expression of genes that encode glycolytic enzymes like aldolase A, enloase 1, lactate dehydrogenase A, phosphofructokinase L, phosphoglycerate kinsae 1, and pyruvate kinase M. Therefore, we investigated alterations in the levels of HIF-1α in the cells throughout the spheroid growth up to 28 days. Indeed we found a higher level of HIF-1α (Fig 5) despite daily feeding of fresh medium to the spheroids, similar to the results reported previously in the unfed spheroids , thereby suggesting that the enhanced glycolysis observed in spheroids could be mainly driven by hypoxia, and might be induced by the over-expression of genes encoding proteins involved in glucose metabolism.
The gene for LDH-A, whose expression is often increased in cancer cells, has been identified as a c-Myc responsive gene , and is also shown to be induced by hypoxia through the activity of HIF-1α . Moreover, c-Myc and HIF-1α binding sites resemble the carbohydrate response element [43–45]. Cells over-expressing c-Myc have been shown to be more susceptible to the induction of apoptosis under stress induced by certain agents as well as in the sub-optimal growth conditions [46, 47]. Therefore, we investigated the level of c-Myc, and indeed observed a three-fold higher level in the spheroidal cells as compared to the monolayer (Fig 5), implying that these cells might be more susceptible to apoptosis and necrosis induced by glucose deprivation.
Mitochondrial activity and generation of reactive oxygen species
Low-LET ionizing radiation produces damage to cellular biomolecules mainly through the generation of ROS initiated by hydroxyl radicals. Apart from hypoxic cell population, enhancement of glycolysis in spheroid cells (as evident from increased glucose usage and lactate production) would result in the reduced generation of ROS following radiation exposure. Studies using confocal microscopy have shown that alterations in ATP level influences the generation of ROS in a concentration-dependent manner . We did not observe any significant difference between the monolayers and spheroids of all ages with respect to the endogenous levels of ROS (Fig 7A).
The ROS generation may be reduced through partial uncoupling of oxidative phosphorylation and by decreasing the transmembrane potential and the redox state of complex 1 . This is achieved by increasing permeability of the inner mitochondrial membrane to K+ and H+ by means of opening mitochondrial K+ channels or by endogenous uncoupling proteins like carnitine palmitoyl tranferases CPT I and II , thereby reducing the mitochondrial membrane potential as seen in spheroids from 7 days to 21 days in culture when compared to monolayers (Fig 8b). Radiation induced ROS was 2–3 times less in the spheroids as compared to the monolayer cells at all the three absorbed doses, and this could be partly responsible for the radioresistance exhibited by the spheroidal cells (Fig 7B). However, increase in ROS most often occurs during the later stages of cell death program where cytoskeletal reorganization as well as disintegration takes place. Further, the level of intracellular ROS to a great extent determines the mode of cell death; low levels of ROS inducing PCD while high levels promotes necrosis or can lead PCD-committed cells towards necrotic-like destruction . While the anti-apoptotic processes and regulators are induced to maintain the homeostasis to a certain extent (the most important family of protein being Bcl-2), alternative pathways might also be responsible for inducing apoptosis and/or necrosis.
In summary, the present study provides a detailed characterization of multicellular spheroids with respect to a number of parameters relevant to studies aimed at evaluating efficacy of tumor therapeutic agents. Characterization of mitochondrial status and oxidative stress levels with the increasing age of multicellular spheroids, coupled with enhanced glycolysis and related variations in HIF-1α and c-Myc will prove useful in optimizing the use of this valuable cellular 3-D tumor model for predicting tumor response to chemotherapeutic/radiosensitizing agents acting on metabolic pathways. In this study, spheroids were regularly fed with fresh medium, which may resemble the in vivo conditions wherein a proportion of cells receive uninterrupted supply of nutrients and oxygen while others become hypoxic and may enter secondary necrosis. Investigations using spheroid model also highlight the inherent limitations of extrapolations made from monolayer studies for application in tumor biology and therapy. The detailed characterization presented here is aimed at obtaining a better understanding of the spheroid model for optimizing and interpreting the predictive therapy trials and drug response of various therapeutic agents and/or adjuvants, particularly metabolic modulators.
The cerebral glioma cell line (BMG-1; wild type p53) was established in Bangalore, India (20). Stock cultures were maintained in the exponentially growing state by passaging twice weekly in DMEM containing 10 mM HEPES and antibiotics supplemented with 5% fetal bovine serum.
BMG-1 spheroids were grown by inoculating 1 × 106 viable cells of BMG1 in non-adherent 90-mm petridishes in 10 ml DMEM supplemented with 5% fetal calf serum, antibiotics and 10 mM HEPES. Clusters of cells could be observed after 24 hours of initiation. However, it took nearly 4 days for these clusters to form spheroids (clusters could not be dislodged by pipetting). Approximately 10,000 spheroids could be obtained in a petridish of ~60 cm2 (90 mm diameter) which were redistributed in to 20 non-adherent 90-mm petridishes containing 10 ml of complete growth medium. The pH of the medium was monitored daily to prevent acidosis. The medium was changed on alternative days till spheroids were 14 day old, followed by redistribution of spheroids from each petridish further to 10 non-adherent petridishes and the medium was changed daily thereafter till 28 days. Unlike other spheroids reported in the literature these spheroids could not be grown for months as they disintegrated after 28 days.
Spheroid growth measurements
Spheroid growth was monitored by measuring the increase in spheroid size as a function of time. Images of spheroids were obtained using the image analysis system consisting of Olympus BX 60 fluorescence microscope and Grundig FA87 monochrome CCD camera. Volume and surface area was calculated using Optimas® image analysis software (Optimas, USA; version 5.0). The size of nearly 50 spheroids was evaluated in each group by measuring two orthogonal diameters (d1 and d2) using the line morphometry function. Volume was calculated using the formula V = 4/3Πr3, where r = 1/2√ d1d2 the geometric mean radius. Average cell number per spheroid was calculated by trypsinizing 10–20 spheroids and the total number of cells obtained was divided by the number of spheroids trypsinized.
Analysis of cell cycle kinetics using BrdU labeling
Cells were incubated with 10 μM BrdU for 30 min at 37°C at various time intervals (7–28 days). Immediately on completion of incubation, an aliquot containing 106 cells from monolayers or spheroidal cell suspension was pelleted by centrifugation (1000 g, 10 min), resuspended in PBS, fixed in 80% ethanol and stored at 4°C until use. For analysis, fixed cells were washed with 0.9% NaCl, incubated with pepsin (0.5% in 0.055 N HCl, pH 1.8) for 10 min at 37°C, washed with saline again, and treated with 2 N HCl for 30 min at room temperature. Following another wash with normal saline and a wash with PBS-Tween (0.05%), the cells were incubated with anti-BrdU antibody (mouse anti-human IgG1; BD Pharmingen, USA) in PBS-Tween at 1:40 dilution for 30 min at 4°C. Cells were then washed twice in PBS-Tween (0.05%)-BSA (1%), and incubated with rabbit antimouse IgG1-FITC conjugate (Sigma) at 1:100 dilution in PBS-Tween-BSA for 30 min at 4°C. After another wash in PBS-Tween-BSA, cells were resuspended in PBS and stained with propidium iodide (50 μg/ml) for 30 min. Fluorescence of propidium iodide (DNA) and FITC (BrdU) was measured simultaneously in the FACS Calibur Flow Cytometer (Becton Dickinson), and biparametric scatter plots were analysed using the CellQuest software. Histograms were analyzed for cell cycle phase distribution by using Modfit software.
Detection of PS-externalization using annexin-V labeling
Membrane asymmetry accompanied by translocation of the phospholipid phosphotidylserine (PS) from inner to the outer side of the plasma membrane is one of the manifestations of apoptosis. Externalization of PS was studied by Annexin V (a phospholipid binding protein) binding assay . Briefly, live cells were washed twice in PBS and resuspended in binding buffer containing 0.01 M HEPES/NaOH, pH 7.4; 0.14 mM NaCl; 2.5 mM CaCl2. Cell suspension (1 × 105 cells in 100 μl) in the binding buffer was incubated with 5 μl of FITC labeled Annexin V (BD Pharmingen, USA) for 15 minutes in the dark at room temperature. Following incubation, propidium iodide was added and fluorescence of cells PI (DNA) and FITC (Annexin) was measured simultaneously in the FACS Calibur Flow Cytometer (Becton Dickinson), and biparametric scatter plots were analysed using the CellQuest software.
Macrocolony assay with dissociated cell population is still considered a reference standard for assessing the survival of cells. This has been extensively employed in studies with ionizing radiation and cytotoxic anticancer drugs, to predict the dose needed to cure transplanted tumors in mice as well as multi-cellular spheroids [52, 53]. Spheroids and monolayers were washed with PBS and irradiated in HBSS using Co-60 teletherapy source (Theratron-780 C, Canada) to access the cell survival. Following irradiation, spheroids and monolayer cultures were dissociated into single cells by trypsinization and counted using haemocytometer. Appropriate number of cells was plated in 60 mm Petri dishes with complete media containing 10% FCS. Plates were incubated at 37°C in a humidified incubator (5% CO2 and 95% air) till colonies were formed (7 days). Methanol fixed colonies was stained with 1% crystal violet and colonies containing more than 50 cells were scored.
Estimation of glucose utilization and lactate production
BMG-1 cells and spheroids were incubated in HBSS or HBSS and 2-DG for 2 h. The amount of glucose remaining unused and the lactate produced were estimated in the buffer using enzymatic assays. Glucose was measured using the reducing sugar method [54–56]. Briefly a mixture of equal volumes of incubating medium (HBSS) and alkaline copper sulphate were incubated at 90°C for 10 minutes, followed by the addition of phosphmolybidic acid was added at room temperature (~27°C). O.D of the resulting chromogen was measured at 540 nm. Lactate was estimated using lactate oxidase method based kit (Randox; cat No.-LC2389). The number of viable cells in spheroids was counted and glucose consumed or lactate produced was normalized with respect to number of viable cells.
Determination of intracellular redox levels
Intracellular redox levels were measured using the fluorescent dye H2DCFDA which is a non-polar compound (Merck England) and yields a fluorescent DCF in the presence of ROS in the cells. Green fluorescence due to intracellularly trapped DCF was collected on the FL1 channel on the log scale. Spheroids and monolayer cells were just washed twice in PBS and held in PBS with Ca2+, Mg2+, H2DCFDA (10 μg/ml) and 5 mM glucose, before irradiation and subsequently incubated for half an hour at 37°C. Cells were trypsinized after a rinse with PBS, washed and resuspended in PBS with Ca2+, Mg2+ and glucose. Samples were stored on ice, and measurements were made within half an hour after trypsinization.
Flow cytometric analysis of mitochondrial mass and activity
Spheroids and monolayers were parallely stained with one of the mitochondrial fluorescent dyes NAO and Rh123, essentially according to the procedure described earlier . Briefly, the unfixed spheroids and monolayers were washed and incubated in PBS (with Ca2+, Mg2+), glucose and NAO (10 μM 10 min at 25°C) or Rh123 (5 μg/ml 30 min. at 37°C), followed by trypsinization washing and resuspension in PBS (with Ca2+, Mg2+ and glucose) and incubated on ice until analysis by the flow cytometer.
Preparation of cell extract and western blotting
Scraped monolayer cells and spheroids were collected at 800 g for 5 minutes, washed twice with 5 ml PBS and sonicated (VC-X 500, Sonics and Materials Inc. USA) on ice in PBS for 1 minute mixed with pre chilled acetone (3 parts) and incubated overnight at -20°C. Following incubation, acetone was removed by centrifugation and pellet was dissolved in autoclaved Milli Q water and protein content was determined by Lowry's method . 2× lysis buffer [62.5 mM Tris Hcl ph 6.8, 10% (v/v) Glycerol 2% (w/v) SDS, 1 mM PMSF, 1 μg/ml pepstatin A, 1 μg/ml leupeptin and 5 μg/ml aprotinin] was added to the pellet and boiled at 100°C for 5 minutes. An equal amount of protein (10–20 μg) was loaded on 10% SDS polyacrylamide gels. Proteins were separated at a constant voltage of 100 V for 1.5 hours and then blotted to PVDF membrane (Amersham) in transfer buffer [25 mM Tris, 192 mM glycine, 15% methanol (v/v)] overnight at 14 V. The blots were blocked with 1% BSA in TTBS [15 mM Tris-HCl pH7.5, NaCl .9% and 0.1% Tween-20] for 1 hour at room temperature (25–28°C). Membranes were incubated with a mouse monoclonal antibody (1:1000) anti Bax (BD Pharmingen, USA), anti Bcl2 (BD Pharmingen, USA) anti c-Myc (BD Pharmingen, USA), anti HIF-1α (Santa Cruz Biotechnology USA) and anti Beta actin (Promega) for 1 hour in TTBS and 1% BSA. Membranes were washed with TTBS four times for 15 minutes each and incubated with anti mouse peroxidase conjugated secondary antibody (1:1000 dilutions; Banglore Genei India) for 1 hour. Blots were washed and developed using ECL chemiluminescence detection reagent (Pierce). Membranes were stripped in stripping buffer (25 mM Glycine, 1% SDS, pH 2 adjusted with HCl) for 1 hour washed twice in TTBS for 10 minutes each and re-probed.
This work was supported by the project INM 280, 301 funded by Defence Research and Development Organisation (DRDO), Government of India.
- Vaupel P, Kallinowski F, Okunieff PG: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989, 49: 6449-6465.PubMedGoogle Scholar
- Kunz-Schughart LA, Groebe K, Mueller-Klieser W: Three dimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation. Int J Cancer. 1996, 66: 578-86. 10.1002/(SICI)1097-0215(19960516)66:4<578::AID-IJC25>3.0.CO;2-2.View ArticlePubMedGoogle Scholar
- Reynaud-Bougnoux A, Lespinasse F, Malaise EP, Guichard M: Partial hypoxia as a cause of radioresistance in a human tumor xenograft: its influence illustrated by the sensitizing effect of misonidazole and hyperbaric oxygen. Int J Radiat Oncol Biol Phys. 1986, 12: 1283-1286.View ArticlePubMedGoogle Scholar
- Olivier C, Raphael S, Jean-Pierre L, Michel L, Emile R, Catherine R: Chronic hypoxia protects against Á-irradiation-induced apoptosis by inducing Bcl-2 up-regulation and inhibiting mitochondrial translocation and conformational change of bax protein. Int J Oncol. 2003, 23: 1033-1041.Google Scholar
- Santini MT, Rainaldi G, Indovina PL: Multicellular spheroids in radiation biology. Int J Rad Biol. 1999, 75: 787-799. 10.1080/095530099139845.View ArticlePubMedGoogle Scholar
- Sanitini MT, Rainaldi G, Indovina PL: Apoptosis, Cell adhesion and extracellular matrix in 3-D growth of multicelluler tumor spheroids. Critical Rev Oncol Hematol. 2001, 36: 75-87.View ArticleGoogle Scholar
- Mueller-Klieser W, Freyer JP, Sutherland RM: Influence of glucose and oxygen supply conditions of multicellular spheroids. Br J Cancer. 1986, 53: 345-53.PubMed CentralView ArticlePubMedGoogle Scholar
- Casciari JJ, Sotirchos SV, Sutherland RM: Glucose Diffusibility in multicellular tumor spheroids. Cancer Res. 1988, 48: 3905-3909.PubMedGoogle Scholar
- Acker H, Holtermann G, Carlson J: Influence of glucose on metabolism and growth of rat Glioma cells in multicelluler spheroid culture. Int J Cancer. 1992, 52: 297-285.View ArticleGoogle Scholar
- Casciari JJ, Sotirchos SV, Sutherland RM: Variation in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol. 1992, 151: 386-394. 10.1002/jcp.1041510220.View ArticlePubMedGoogle Scholar
- Dwarkanath BS, Jain VK: Energy linked modification of the radiation response in human cerebral glioma cell line. Int J Rad Oncl Bio Phys. 1989, 17: 1033-1040.View ArticleGoogle Scholar
- Dwarkanath BS, Jain VK: Effects of gamma rays and glucose analogs on energy metabolism of a cell line derived from human cerebral glioma. Ind J Biochem Biophy. 1991, 28: 203-209.Google Scholar
- Dwarakanath BS, Zolzar FJ, Chandana S: Heterogeneity in 2-DG induced modifications in energetics and radiation responses of human tumor cell lines. Int J Rad Onc Bio Phys. 2001, 50: 1051-1061. 10.1016/S0360-3016(01)01534-6.View ArticleGoogle Scholar
- Jain VK, Porschen W: Optimization of cancer therapy part II, effects of combining 2-DG treatment with gamma irradiation on sarcoma-180. Indi J Exp Biol. 1977, 15: 714-718.Google Scholar
- Jain VK, Kalia VK, Sharma R: Effects of 2-DG on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int J Rad Onc Bio Phys. 1985, 11: 943-950.View ArticleGoogle Scholar
- Jha B, Pohlit W: Reversibility of inhibition of DNA double strand break repair by 2-dexoy-D-glucose in Ehrlich ascites tumor cells. Int J Radiat Biol. 1993, 63: 459-467.View ArticlePubMedGoogle Scholar
- Dwarkanath BS, Jain VK: Enhancement of radiation damage by 2-DG in organ culture of brain tumors. Ind J Med Res. 1985, 82: 266-268.Google Scholar
- Dwarkanath BS, Jain VK: Modification of the radiation induced damage by 2-deoxy-D-glucose in organ cultures of human cerebral gliomas. Int J Radiat Oncol Biol Phys. 1987, 13: 741-746.View ArticleGoogle Scholar
- Schwachofer JH: Multicellular tumor spheroids in radiotherapy research. Rev Antican Res. 1990, 10: 963-969.Google Scholar
- Dwarkanath BS: Energy metabolism and repair of radiation induced damage in brain tumors. National Institute of Mental Health and Neurosciences Bangalore India. 1988Google Scholar
- Dwarakanath BS, Adhikari JS, Jain V: Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-DG in cancer cells. Int J Radiat Oncol Biol Phy. 1999, 43: 1125-1133. 10.1016/S0360-3016(98)00465-9.View ArticleGoogle Scholar
- Vermes IC, Haanen H, Steffens-Nakken , Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Meth. 1995, 184: 39-51. 10.1016/0022-1759(95)00072-I.View ArticleGoogle Scholar
- Sutherland M: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988, 240: 177-184.View ArticlePubMedGoogle Scholar
- Freyer JP: Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res. 1988, 48: 2432-2439.PubMedGoogle Scholar
- Durand RE: Multicell spheroids as a model for cell kinetic studies. Cell Tissue Kinet. 1990, 23: 141-159.PubMedGoogle Scholar
- Casciari JJ, Sotirchos SV, Sutherland RM: Mathematical modelling of microenvironment and growth in EMT6/Ro multicellular tumor spheroids. Cell Prolif. 1992, 25: 1-22.View ArticlePubMedGoogle Scholar
- Freyer JP, Schor PL, Saponara AG: Partial purification of a protein growth inhibitor from multicellular spheroids. Biochem Biophys Res Commun. 1988, 152: 463-8. 10.1016/S0006-291X(88)80736-8.View ArticlePubMedGoogle Scholar
- Cogner AD, ziskim MC: Growth of mammalian multicellular tumor spheroids. Cancer Res. 1983, 43: 556-560.Google Scholar
- Gerweck LE, Seneviratne T, Gerweck KK: Energy status and radiobiological hypoxia at specified oxygen concentration. Radiat Res. 1993, 135: 69-74.View ArticlePubMedGoogle Scholar
- Yao KS, Clayton M, Dwyer PJ: Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Nat Can Inst. 1995, 87: 117-122.View ArticleGoogle Scholar
- Ward JF: Radiation mutagenesis: the initial DNA lesion responsible. Radiat Res. 1995, 142: 362-368.View ArticlePubMedGoogle Scholar
- Rutz HP, Little JB: Exogenous lactate modifies the repair of Potentially Lethal Damage in three human tumor cell lines irradiated in vitro. Radiat Res. 1990, 24: 110-113.View ArticleGoogle Scholar
- Mothersill C, Seymour CB: Effect of lactate on the recovery of CHK1 cells from gamma radiation damage. Acta Radiol Oncol. 1986, 25: 71-76.View ArticlePubMedGoogle Scholar
- Padma MV, Said S, Jacobs M: Prediction of pathology and survival by FDG PET in gliomas. J Neuro-oncol. 2003, 64: 227-237. 10.1023/A:1025665820001.View ArticleGoogle Scholar
- Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside TL: Over expression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer. 2003, 97: 1015-1024. 10.1002/cncr.11159.View ArticlePubMedGoogle Scholar
- Casciari J, Sotirchos SV, Sutherland RM: Glucose diffusivity in multicellular tumor spheroids. Cancer Res. 1988, 48: 3905-3909.PubMedGoogle Scholar
- Rodriguez-Enriquez S, Moreno-Sanchez R: Intermediary metabolism of fast-growth tumor cells. Arch Med Res. 1998, 29: 1-12.PubMedGoogle Scholar
- Bustamante E, Morris HP, Pedersen PL: Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem. 1981, 256: 8699-8704.PubMedGoogle Scholar
- Arora KK, Pedersen PL: Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intra mitochondrially generated ATP. J Biol Chem. 1988, 263: 17422-17428.PubMedGoogle Scholar
- Parry DM, Pedersen PL: Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J Biol Chem. 1983, 258: 10904-10912.PubMedGoogle Scholar
- Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla Favera R, Dang CV: c-Myc transactivation of LDHA: implications for tumor metabolism and growth. Proc Natl Acad Sci USA. 1997, 94: 6658-6663. 10.1073/pnas.94.13.6658.PubMed CentralView ArticlePubMedGoogle Scholar
- Semenza GL, Roth PH, Fang HM, Wang GL: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994, 269: 23757-23763.PubMedGoogle Scholar
- Semenza GL, Dang CV: Oncogenic alterations of metabolism. Trends Biochem Sci. 1999, 24: 68-72. 10.1016/S0968-0004(98)01344-9.View ArticlePubMedGoogle Scholar
- Firth JD, Ebert BL, Ratcliffe PJ: Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia inducible factor 1 and cAMP response elements. J Biol Chem. 1995, 270: 21021-21027. 10.1074/jbc.270.49.29083.View ArticlePubMedGoogle Scholar
- Semenza GL: Hypoxia-inducible factor 1: Master regulator of oxygen homeostasis. Curr Opin Genet Dev. 1998, 8: 588-594. 10.1016/S0959-437X(98)80016-6.View ArticlePubMedGoogle Scholar
- Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992, 69: 119-28. 10.1016/0092-8674(92)90123-T.View ArticlePubMedGoogle Scholar
- Gibson AW, Cheng T, Johnston RN: Apoptosis induced by c-myc overexpression is dependent on growth conditions. Exp Cell Res. 1995, 218: 351-8. 10.1006/excr.1995.1166.View ArticlePubMedGoogle Scholar
- Sauer H, Klimn B, Hescheler J, Waternberg M: Activation of p90RSK and growth stimulation of multicellular tumor spheroids is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. FASEB J. 2001, 17-Google Scholar
- Skulachev VP: Role of uncoupled and non coupled oxidants in maintenance of safely low levels of oxygen and its one electron reductants. Q Rec Biophys. 1996, 29: 169-202.View ArticleGoogle Scholar
- Kerner J, Hoppel C: Fatty acid import into mitochondria. Biochem Biophys Acta. 2000, 1486: 1-17.PubMedGoogle Scholar
- Guenal I, Sidoti-de Fraisse C, Mignotte B: Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene. 1997, 15: 347-360. 10.1038/sj.onc.1201182.View ArticlePubMedGoogle Scholar
- Reinhold HS, De Bree C: Tumour cure rate and cell survival of a transplantable rat rhabdomyosarcoma following x-irradiation. Eur J Cancer. 1968, 4: 367-374.View ArticlePubMedGoogle Scholar
- Durand RE: Cure, regression and cell survival: a comparison of common radiobiological endpoints using an in vitro tumour model. Br J Radiol. 1975, 48: 556-571.View ArticlePubMedGoogle Scholar
- Philip A, Shaffer , Michael S: Copper-iodometric reagents for sugar determination. J Biol Chem. 1933, 100: 695-713.Google Scholar
- Michael S: A reagent for the copper-iodometric determination of very small amounts of sugar. J Biol Chem. 1937, 117: 771-776.Google Scholar
- Norton N: A photometric adaptation of the somogyi method for the determination of glucose. J Biol Chem. 1944, 153: 375-380.Google Scholar
- Darzynkiewicz Z, Staiano-Coico L, Melamed MR: Increased Mitochondrial Uptake of Rhodamine 123 during Lymphocyte Stimulation. Proc Natl Acad Sci USA. 1981, 78: 2383-2387.PubMed CentralView ArticlePubMedGoogle Scholar
- Lowry OH, Rosebrough JN, Farr AL, Randall JR: Protein measurement with the folin phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.